UK | pharmaphorum

UK

News

UK government rubberstamps millions of extra COVID vaccines

The UK government has placed a 114 million-dose order with Pfizer/BioNTech and Moderna – sufficient to provide two doses to every person in Britain – in a bid to future-proof against COVID-

News

Talking vaccines: Industry’s role in protecting the Gavi generation

UK accelerates COVID booster plans in response to Omicron

The UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of cases of the new Omicron variant of SARS-CoV-2 has reached double figures.

News

Report suggests UK's national vaccine facility is on the blo...

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale.

News

AstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridge

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Valneva gets EU deal for COVID jab, and may sue UK

Shares in France's Valneva leaped after it got an EU order to supply 60 million doses of its COVID-19 vaccine VLA2001 over the next two years, including 27 million next year.

News

Industry welcomes boost to health research in UK budget

Groups representing the biopharma industry have welcomed an increase in health-specific R&D to £5 billion in the UK autumn budget, despite a longer timeline for reaching the target of £

UK government rubberstamps millions of extra COVID vaccines

UK accelerates COVID booster plans in response to Omicron

Report suggests UK's national vaccine facility is on the blo...

AstraZeneca cuts the ribbon on its $1bn R&D lab in Cambridge

Valneva gets EU deal for COVID jab, and may sue UK

Industry welcomes boost to health research in UK budget

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

UK

Editor's Picks